‘Safe and Effective’: New CDC Data Reveals Information on JYNNEOS Mpox Vaccine

‘Safe and Effective’: New CDC Data Reveals Information on JYNNEOS Mpox Vaccine

More than 29,000 cases of mpox, formerly known as monkeypox, have been reported in the U.S.

New data from two recently published studies from the Center for Disease Control and Prevention (CDC) show that the JYNNEOS mpox vaccine is both “safe” and “effective,” the agency said.

According to a media statement, the first report, published on December 9, found that although there were some side effects—like dizziness or pain at the location of the vaccine—to the JYNNEOS mpox vaccine, there were “no major vaccine safety concerns” after about one million vaccines were provided.

In the second report, also published on December 9, researchers looked at the rate of mpox illness between unvaccinated and vaccinated people. In people who only had one of the two mpox doses, rates were 7.4 times higher than fully vaccinated people. The rate increased for those who were completely unvaccinated to 9.6.

“Mpox cases are decreasing, but so is public concern,” said Jonathan Mermin, M.D., M.P.H., mpox response Incident Manager in the media statement. “With a safe, effective vaccine in our hands, this is our chance to turn the page and finish strong.”

As of December 7, there were 29,711 cases of mpox, previously called monkeypox, in the U.S. Most of the cases were reported in California, 5,604, and New York, 4,180, with Texas, Florida and Georgia also reporting high numbers.

The CDC provides guidance on the prevention of the virus in some workplace settings. Healthcare personnel should correctly use PPE. For those who work in a setting where people share housing, the CDC has various guidelines on responding to positive cases. Those who may be exposed to the virus at work are recommended to get vaccinated.

In September, California posted guidance on how to keep workers safe from mpox in the workplace.

Photo credit: Richard H Grant / Shutterstock.com

About the Author

Alex Saurman is a former Content Editor for Occupational Health & Safety,who has since joined OH&S’s client services team. She continues to work closely with OH&S’s editorial team and contributes to the magazine.

Product Showcase

  • AirChek Connect Sampling Pump

    Stay connected to your sampling with the SKC AirChek® Connect Sampling Pump! With its Bluetooth connection to PC and mobile devices, you can monitor AirChek Connect pump operation without disrupting workflow. SKC designed AirChek Connect specifically for all OEHS professionals to ensure accurate, reliable flows from 5 to 5000 ml/min and extreme ease of use. AirChek Connect offers easy touch screen operation and flexibility. It is quality built to serve you and the workers you protect. Ask about special pricing and a demo at AIHA Connect Booth 1003. Read More

  • Safety Shower Test Cart

    The Safety Shower Test Cart speeds up and simplifies emergency shower tests, ensures you stay in compliance with OSHA regulations, and significantly reduces testing costs. With 7 unique features, the cart makes testing easy, effective, and efficient. You can test water clarity, flow, temperature, and spread—all at the same time! Most safety shower testing kits create a mess, take too much time to use, and don't fully help you stay in compliance with OSHA & ANSI standards. Transform the way you test emergency showers with Green Gobbler Safety. Read More

  • SwabTek® Cannabis Test Kit

    The SwabTek® Cannabis Test Kit is a single-use spot test designed for use in screening for cannabis compounds in any sample type or on any surface. The test is capable of identifying the presumed presence of cannabinoids in very small quantities, with a level of detection as little as 6 μg in mass. Learn more about the SwabTek® Cannabis Test Kit and the rest of SwabTek surface drug testing solutions through the webinar titled "Everything You Want To Know About Surface Testing" Read More

Featured

Webinars